Comparison

CardioGenetics vs Onsera

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

CardioGenetics

This medical app provides healthcare professionals with validated calculators, diagnostic frameworks, and a clinical trial finder for inherited cardiomyopathies. It offers evidence-based risk stratification aligned with current guidelines, supporting clinical decision-making at the bedside and in conference.

Highlights
  • Validated risk calculators
  • Diagnostic frameworks
  • Clinical trial finder
  • Guideline-linked evidence
  • Gene-specific risk assessment
  • ASCVD risk calculation
Features
Read full description

Every inherited cardiomyopathy evaluation warrants meticulous, accurate, and evidence-based risk stratification. CardioGenetics compiles validated calculators, diagnostic frameworks, and a live clinical trial finder in your pocket. USED AT THE BEDSIDE Whether you are presenting at a multidisciplinary cardiomyopathy board, interpreting a new pathogenic variant, or seeing your first LMNA patient, CardioGenetics gives the same tools with the evidence and models behind every number. ASCVD RISK ALIGNED WITH THE 2026 GUIDELINES Calculate 10-year risk with AHA PREVENT (ages 30–79), compare against the legacy Pooled Cohort Equations, integrate coronary artery calcium via the MESA score, and interpret Lipoprotein(a) with a built-in risk multiplier. Every result maps directly to the 2026 ACC/AHA dyslipidemia guideline statin thresholds, risk-enhancing factors, and CAC decision pathways. GENE-SPECIFIC SUDDEN CARDIAC DEATH RISK Not all cardiomyopathies carry the same arrhythmic risk. CardioGenetics includes dedicated calculators for HCM (ESC 2014 Risk-SCD), ARVC (Cadrin-Tourigny), LMNA (Wahbi, ESC 2023-adapted), PLN p.Arg14del (Verstraelen), DSP (ERADOS, Eur Heart J 2024), FLNC (Gigli, JAMA Cardiol 2025), and PKP2-specific guidance. Each cross-referenced to the latest ESC 2023 and AHA/ACC 2024 guidelines. DIAGNOSTIC FRAMEWORKS AT YOUR FINGERTIPS Confirm diagnoses before you risk-stratify. Built-in criteria include the 2020 Padua Criteria for arrhythmogenic cardiomyopathy, AHA/ACC 2024 and ESC 2023 HCM diagnostic standards, LVNC scoring (Jenni, Petersen, Stöllberger), and DCM phenotyping. FIND THE RIGHT CLINICAL TRIAL Browse actively enrolling studies for Lp(a), HCM, ACM/ARVC, DSP, LMNA, and PLN with interactive U.S. state and European enrollment maps. Every trial includes its NCT identifier and a direct link to ClinicalTrials.gov. DESIGNED FOR WHAT WE ACTUALLY DO IN CLINIC • Search any calculator, diagnosis, or trial from a single search bar • Tap a risk score and see the full mathematical model, original citation, and DOI • View sensitivity analyses and interactive risk curves • Share lay-language summaries during patient-facing discussions • Cross-navigate between diagnostic confirmation and risk stratification in one tap TRUST BUT VERIFY: Every calculator reproduces its published equation with full variable definitions and baseline coefficients. There are no "black boxes" here, no proprietary modifications. Tap any citation to access the original published manuscript. INTENDED USERS: Cardiologists · Electrophysiologists · Genetic Counselors · Cardiology Fellows and Residents · Medical Students · Advanced Practice Providers · Inherited Cardiovascular Disease Teams Developed by Mark E. Pepin, MD, PhD, FESC. All risk models are derived from peer-reviewed literature and their original sources. This app is a clinical decision-support aid for healthcare professionals and does not replace clinical judgment, institutional protocols, or shared decision-making. Not FDA-cleared or CE-marked.

About

Onsera

Features
Read full description

Onsera is a comprehensive weight management platform designed to support participants through every stage of their weight loss and cardiometabolic health journey. Available as an employer-sponsored health benefit, Onsera connects participants with a dedicated clinical team, personalized coaching, and access to FDA-approved medications when clinically appropriate. What's inside: • A guided onboarding to understand your health history and goals • Clinical care from licensed providers experienced in obesity medicine • Medication management with simple pharmacy coordination, when prescribed • Progress tracking using connected devices and weekly check-ins • Secure messaging with your care team Why Onsera: Weight care should treat the whole person, not just the number on the scale. Our care model brings together evidence-based clinical practice, behavioral coaching, and the latest tools in metabolic health, all delivered through a thoughtful mobile experience. Eligibility: Onsera is currently offered through participating employers and health plans. To check if you have access, ask your benefits team or visit app.onserahealth.com/signup. Your privacy: We protect your health information with industry-standard security practices and comply with HIPAA. You control what you share and with whom. Read our privacy policy here at https://onserahealth.com/privacypolicy. Medical disclaimer: Onsera provides health-related information and connects participants with licensed clinicians. It is not a substitute for emergency medical care. If you are experiencing a medical emergency, call 911 or your local emergency number.

Screenshots

CardioGenetics4 screens
Onsera4 screens

Verdict

The call

The clearest difference is price: Onsera at Free against CardioGenetics's $2.99. Onsera also leads on update cadence (every 3 weeks vs every 5 months). On ads, in-app purchases, device support and iOS requirement there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Onsera is free to download; CardioGenetics costs $2.99 up front. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

CardioGenetics ships an update every 5 months, Onsera every 3 weeks. The most recent releases landed on September 23, 2026 and October 6, 2026 respectively.

Scorecard2 real differences · 8 level
CardioGenetics versus Onsera: the parameters behind the verdict, then further details
ParameterCardioGeneticsOnsera
Price$2.99Free — better
Rating5.0 (4 ratings) — better—
Positive reviews100.0% of reviews—
Number of ratings4 — better—
Update frequencyEvery 5 monthsEvery 3 weeks — better
AdsNoNo
In-app purchasesNoNo
MonetizationPaid—
DevicesiPhone, iPad — betteriPhone
Requires iOS17.016.4 — better
Further details — not scored
Size6 MB157 MB
Age rating4+17+
DeveloperMARK EMILE PEPINOnsera Health, Inc.

In-app purchases

None

CardioGenetics

No in-app purchases

None

Onsera

No in-app purchases

Questions

Is CardioGenetics free?
CardioGenetics costs $2.99, with no in-app purchases.
Is Onsera free?
Onsera is free to download, with no in-app purchases.
Do CardioGenetics or Onsera have ads?
Neither CardioGenetics nor Onsera shows ads.
Which is updated more often, CardioGenetics or Onsera?
CardioGenetics ships an update every 5 months, and Onsera every 3 weeks. Most recently, CardioGenetics was updated on September 23, 2026 and Onsera on October 6, 2026.

Other comparisons